Erinc Hallacli

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Transcription Factor

Endothelial Cells

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)